295 related articles for article (PubMed ID: 27223121)
41. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
42. Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors.
Schaefer IM; Dong F; Garcia EP; Fletcher CDM; Jo VY
Am J Surg Pathol; 2019 Jun; 43(6):835-843. PubMed ID: 30864974
[TBL] [Abstract][Full Text] [Related]
43. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
44. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
[TBL] [Abstract][Full Text] [Related]
45. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
[TBL] [Abstract][Full Text] [Related]
46. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
Rekhi B; Thomas A
Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis.
Rekhi B; Kosemehmetoglu K; Tezel GG; Dervisoglu S
APMIS; 2017 Aug; 125(8):679-689. PubMed ID: 28452074
[TBL] [Abstract][Full Text] [Related]
48. Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.
Rao UN; Cieply K; Sherer C; Surti U; Gollin SM
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):168-177. PubMed ID: 26808135
[TBL] [Abstract][Full Text] [Related]
49. Molecular and Clinicopathologic Heterogeneity of Intracranial Tumors Mimicking Extraskeletal Myxoid Chondrosarcoma.
Velz J; Agaimy A; Frontzek K; Neidert MC; Bozinov O; Wagner U; Fritz C; Coras R; Hofer S; Bode-Lesniewska B; Rushing E
J Neuropathol Exp Neurol; 2018 Aug; 77(8):727-735. PubMed ID: 29924341
[TBL] [Abstract][Full Text] [Related]
50. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
51. SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases.
Jo VY; Fletcher CDM
Am J Surg Pathol; 2017 Aug; 41(8):1013-1022. PubMed ID: 28368924
[TBL] [Abstract][Full Text] [Related]
52. Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors.
Lanzi C; Arrighetti N; Pasquali S; Cassinelli G
Biochem Pharmacol; 2023 Sep; 215():115727. PubMed ID: 37541451
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
[TBL] [Abstract][Full Text] [Related]
54. Subclassification of epithelioid sarcoma with potential therapeutic impact.
Haefliger S; Chervova O; Davies C; Nottley S; Hargreaves S; Sumathi VP; Amary F; Tirabosco R; Pillay N; Beck S; Flanagan AM; Lyskjaer I
J Pathol; 2023 Aug; 260(4):368-375. PubMed ID: 37316954
[TBL] [Abstract][Full Text] [Related]
55. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
[TBL] [Abstract][Full Text] [Related]
56. Identification of a blood-borne miRNA signature of synovial sarcoma.
Fricke A; Ullrich PV; Heinz J; Pfeifer D; Scholber J; Herget GW; Hauschild O; Bronsert P; Stark GB; Bannasch H; Eisenhardt SU; Braig D
Mol Cancer; 2015 Aug; 14():151. PubMed ID: 26250552
[TBL] [Abstract][Full Text] [Related]
57. p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.
Oppel F; Shao S; Gendreizig S; Zimmerman MW; Schürmann M; Flavian VF; Goon P; Chi SN; Aster JC; Sudhoff H; Look AT
Mol Cancer Ther; 2022 Nov; 21(11):1689-1700. PubMed ID: 36099437
[TBL] [Abstract][Full Text] [Related]
58. Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm.
Kinoshita I; Kohashi K; Yamamoto H; Yamada Y; Inoue T; Higaki K; Teramoto N; Oshiro Y; Nakashima Y; Oda Y
Histopathology; 2021 Oct; 79(4):629-641. PubMed ID: 33932047
[TBL] [Abstract][Full Text] [Related]
59. Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma.
Mularz K; Harazin-Lechowska A; Ambicka A; Kruczak A; Rozmus-Piętoń M; Marchińska-Osika U; Swiątkiewicz I; Król M; Pabis D; Januś G; Ryś J
Pol J Pathol; 2012 Nov; 63(3):179-83. PubMed ID: 23161234
[TBL] [Abstract][Full Text] [Related]
60. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]